Ozempic-Maker Novo Stops Work on Cell Therapy Cure for Type 1 Diabetes
Novo Nordisk A/S cut its cell therapy division, which has been trying to find a cure for type…
Stock market news for Oct. 9, 2025
A trader works at the New York Stock Exchange on Oct. 3, 2025. NYSE The S&P 500 and…
Novo Nordisk to buy Akero Therapeutics for up to $5.2 billion
A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of…